2001
DOI: 10.1507/endocrj.48.81
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Significance of the Insulin Resistance Index as Assessed by Homeostasis Model Assessment.

Abstract: Abstract.To examine the clinical significance of the insulin resistance index as determined by homeostasis model assessment (HOMA-IR), we investigated the relationship between HOMA-IR and the insulin resistance estimated by the euglycemic-hyperinsulinemic clamp method in various subgroups and compared the significance of HOMA-IR with that of fasting plasma insulin levels (FIRI). HOMA-IR was significantly correlated to the inverse of the glucose infusion rate (1/GIR) in both diabetic and non-diabetic subjects (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
77
1
6

Year Published

2004
2004
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 117 publications
(87 citation statements)
references
References 10 publications
3
77
1
6
Order By: Relevance
“…15 Previously, fasting insulin has been reported to be as accurate as HOMA IR, Bennetts index and the insulin-to-glucose ratio, for prediction of insulin resistance in normoglycaemic subjects. [19][20][21] In the present study, correlations between Si and the insulin-to-glucose ratio and Bennetts index were weaker than other surrogate markers and did not reach significance. However, fasting insulin did show a significant moderate relationship with Si and may be useful in situations where fasting glucose concentrations are unavailable.…”
Section: Discussioncontrasting
confidence: 83%
See 1 more Smart Citation
“…15 Previously, fasting insulin has been reported to be as accurate as HOMA IR, Bennetts index and the insulin-to-glucose ratio, for prediction of insulin resistance in normoglycaemic subjects. [19][20][21] In the present study, correlations between Si and the insulin-to-glucose ratio and Bennetts index were weaker than other surrogate markers and did not reach significance. However, fasting insulin did show a significant moderate relationship with Si and may be useful in situations where fasting glucose concentrations are unavailable.…”
Section: Discussioncontrasting
confidence: 83%
“…15 Other surrogate methods, including fasting insulin, 16 Bennetts index 17 and the insulin-to-glucose ratio, 18 also demonstrate good concordance with values obtained using the more invasive techniques. [19][20][21] The recently developed quantitative insulin-sensitivity check index (QUICKI), 22 which takes the product of both the reciprocal and the logarithm of fasted insulin and glucose concentrations, gives values that correlate well with the glucose-clamp and minimal model techniques and may provide a better surrogate measure of insulin resistance compared to HOMA IR. 22 The revised version of QUICKI (revised QUICKI) 23 that incorporates a value for fasting nonesterified fatty acids (NEFA) into the QUICKI formula is reported to have a stronger relationship with the glucose clamp than QUICKI alone and therefore may provide an adequate substitute for more sophisticated measures of insulin sensitivity.…”
Section: Introductionmentioning
confidence: 99%
“…The validity of these estimates in relation to the clamp technique has been examined in several studies, in a wide variety of populations. [13][14][15][16][17][18][19][20] However, data on their validity in hypertensive populations are generally limited. Recently, McAuley et al 21 proposed another index, which uses fasting insulin and triglyceride values, to be a strong predictor of clamp-derived IS, but this index was not adequately further investigated.…”
Section: Introductionmentioning
confidence: 99%
“…O índice HOMA -Homeostasis Assesment Model, descrito por Matthews et al, (1985), é um modelo matemático que tem sido validado diante do padrão ouro, o clamp euglicêmico hiperinsulinêmico, e vem sendo utilizado por vários autores dando sustentação ao seu uso principalmente em estudos epidemiológicos (Bonora et al, 2000;Haffner et al, 1996;Ikeda et al, 2001;Straczkowski et al, 2003;Yokoyama, et al, 2004;Straczkowski et al, 2004). O HOMA pode ser usado com os pacientes em jejum como em estudos fi siológicos onde esses parâmetros são avaliados mediante prova funcional como o TOTG (Wallace et al, 2004).…”
Section: Resultsunclassified